Avrygen is Leading Gene Therapy Innovation
Company Overview
Avrygen is a biotechnology company focused on developing gene therapies for bone and muscle diseases. Our NanoKor® platform technology, aims to address limitations of existing gene therapy approaches. Avrygen specializes in developing gene therapies for conditions like osteoarthritis, rheumatoid arthritis, osteoporosis, and muscle wasting disorders.
Technology - NanoKor®
The NanoKor® platform, is designed to overcome challenges associated with traditional gene therapy methods, such as efficient delivery and immune response. The NanoKor® platform technology overcomes many of the shortcomings of current nucleotide delivery formulations.
Contact Us
Want to learn more about AvryGen or have a question about our approach? Use the contact form and let’s start a conversation.